TNF and ganglioneuroma: GN administration increased the concentrations of TNF-α (15.30 ± 0.05 pg/mL vs. 9.01 ± 0.08 pg/mL) in the kidney homogenate and in the serum compared to the controls (82.8 ± 12.9 pg/mL vs. 63.2 ± 22.0 pg/mL).